Adapted Probiotic Strains for Pomegranate Extract Tolerance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current probiotic technologies lack efficient methods to enhance the adaptive response of lactobacilli strains to pomegranate extract, which limits their bioactivity and bioavailability, and there is a need for strains that can rapidly grow and tolerate pomegranate extract for improved health benefits.
Innovation Solution
A method involving pre-culturing probiotic bacteria in a culture medium with pomegranate extract to select and produce strains that exhibit a shorter lag phase, increased tolerance, and higher optical density, thereby adapting them for enhanced growth and bioconversion of pomegranate phytochemicals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If probiotic bacteria are pre-cultured in a culture medium with pomegranate extract, then the bacteria exhibit shorter lag phase and increased tolerance to pomegranate extract, but the method complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-culturing probiotic bacteria in a culture medium containing pomegranate extract before the actual application. This pre-culture step allows the bacteria to adapt to and tolerate pomegranate extract in advance, resulting in shorter lag phases and enhanced survival when exposed to pomegranate in the gut or during storage. The preliminary adaptation process resolves the contradiction by preparing the bacteria in advance, making them more reliable for therapeutic use without requiring complex real-time adjustments.
2Quantity of substance
If probiotic bacteria are pre-cultured in a culture medium with pomegranate extract, then the bacteria exhibit increased final optical density and higher growth rates, but the fermentation time may be affected
Solution Approach 1:
The patent uses preliminary action to pre-culture bacteria in pomegranate-containing medium, allowing them to build up biomass and adapt their metabolic pathways before the main application. This results in higher final optical density and growth rates during subsequent cultivation phases, as the bacteria are already in an optimized growth state rather than starting from scratch.
3Reliability
If targeted strains of bacteria such as lactobacilli are used to positively influence the gut microbiota, then the health benefits are improved, but the selection and production process becomes more difficult
Solution Approach 1:
The patent applies parameter changes by using pomegranate extract as a selective agent in the culture medium. This creates specific growth conditions (chemical composition, pH, antioxidant environment) that favor the survival and proliferation of beneficial lactobacilli strains while inhibiting harmful bacteria. By adjusting the cultural parameters to include pomegranate extract, the process becomes more efficient for selecting and producing health-beneficial strains, resolving the contradiction between improving health benefits and maintaining ease of manufacture.
4Quantity of substance
If phytochemicals occur as glyco-conjugates, then their bioavailability is reduced, but the deglycosylation process requires additional enzymatic activity
Solution Approach 1:
The patent applies self-service by utilizing the probiotic bacteria's own enzymatic capabilities to perform deglycosylation of pomegranate glyco-conjugates. The bacteria possess endogenous enzymes (such as beta-glucosidases) that automatically break down the glycosylated forms of phytochemicals into their active aglycone derivatives during the fermentation process. This self-service mechanism eliminates the need for separate enzymatic treatment steps, resolving the contradiction between improving bioavailability and reducing process complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The adapted probiotic strains demonstrate improved growth rates, tolerance to pomegranate extract, and increased bioconversion capabilities, leading to enhanced health benefits and therapeutic applications for digestive and inflammatory diseases.
Implementation Method 1
a probiotic bacterium capable of an adaptive response, wherein the probiotic bacterium has been pre-cultured in a culture medium comprising pomegranate extract
Implementation Method 2
the health-impact of human gut microbiota (HGM)-mediated biotransformation of drug and diet-derived xenobiotics, including phytochemicals
Implementation Method 3
determining if the pre-cultured bacterial population has a shorter time to lag phase and/or increased final optical density (OD) and/or increased tolerance to pomegranate extract
Data Source
AI summary
The invention relates to probiotic compositions, sachets, and nutritional supplements comprising a probiotic bacterium capable of an adaptive response resulting from growth in the presence of pomegranate extract, as well as methods of selecting, producing, and using thereof.